AIS	Analogue Intoxication Scale
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
ANOVA	Analysis of Variance
AP5	DL-2-amino-5-phosphonopentanoic acid
AOS	Adolescence-onset schizophrenia
BMI	Body Mass Index
BSPS	Brief Social Phobia Scale
BSS	Bodily Symptoms Scale
CAPS	Clinician-Administered Posttraumatic Scale
CBD	Cannabidiol
CB1R	Cannabinoid type 1 receptor
CGI	Clinical Global Impression
CGI-C	Clinical Global Impression of Change
CGI-I	Clinical Global Impression of Improvement
CGI-S	Clinical Global Impression of Severity
COWAT	Controlled Oral Word Association Test
CT	Computed Tomography
DSM-IV	Diagnostic and Statistical Manual of Mental Disorders
DSST	Digit-Symbol Substitution Test
DTI	Diffusion Tensor Imaging
GABA	Gamma-Aminobutyric Acid
GAF	Global Assessment of Functioning
LSD	Lysergic Acid Diethylamide
MINI-SPIN	Mini Social Phobia Inventory
MM	Medical Marijuana
MRI	Magnetic Resonance Imaging
NES	Nightmare Effects Survey
NFQ	Nightmare Frequency Questionnaire
PTSD	Post-Traumatic Stress Disorder
REM	Rapid Eye Movement
SAD	Social Anxiety Disorder
SCID-CV	Structured Clinical Interview for DSM-IV, Clinical Version
SCR	Skin Conductance Response
SIPD	Substance-induced psychotic disorder
SPECT	Single-Photon Emission Computerized Tomography
SPIN	Social Phobia Inventory
SPM8	Statistical Parametric Mapping
SPS	Simulated Public Speaking
SPSS-N	Negative Self-Statements Public Speaking Scale
SPST	Simulation Public Speaking Test
STAI	Spielberger State-Trait Anxiety Inventory
STU	Secure Treatment Unit
THC	Tetrahydrocannabinol
TRPV1	Transient Receptor Potential Vanilloid type 1 channel
US	United States
VAMS	Visual Analog Mood Scale
VBM	Voxel-based morphometry
WBQ	General Well Being Questionnaire
WMS-III	Wechsler Memory Scale (3rd edition)
5-HT1a	5-hydroxytryptamine (serotonin) 1A receptor
18-FDG-PET	18-Fluoro-2-deoxyglucose Positron Emission Tomography
Δ9-THC	Delta-9-tetrahydrocannabinol